HealthDay News — For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions, including ...
Attribution (BY): Credit must be given to the creator. Lipidated analogues of glucagon-like peptide 1 (GLP-1) have gained enormous attention as long-acting peptide therapeutics for type 2 diabetes and ...
A team of Chinese scientists has used targeted gene editing to develop rice that produces coenzyme Q10 (CoQ10), a vital ...
A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!
In a study published in Nature Structural and Molecular Biology, scientists from the Department of Medical Biochemistry and ...
A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...
Dr Pandey shares key insights on dosing, monitoring, and patient education to sustain therapy and improve outcomes. Essential for cardiologists and PCPs!
Researchers from Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical ...
Director Rishab Shetty and Hombale Films are leaving no stone unturned for the highly anticipated Kantara: Chapter 1. Production has commenced on the film’s climax, an elaborate war sequence ...
Put simply, Titans could mark the beginning of an AI paradigm shift, bringing machine intelligence a step closer to human-like cognition ... high even as the input sequence length increases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback